Holen Sie sich die Stockscreener-App
2.791
1.75%
-0.069
Curevac N V Aktie (CVAC) Neueste Nachrichten
CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV - ACCESS Newswire
CureVac (NASDAQ:CVAC) Stock Price Down 7.2%What's Next? - MarketBeat
CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions (NASDAQ:CVAC) - Seeking Alpha
CureVac (CVAC) Stock Surges After Favorable Patent Ruling - Stocks Telegraph
European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps - Benzinga
Lululemon, General Motors and Apple fall premarket; CureVac gains By Investing.com - Investing.com Canada
Lululemon, General Motors and Apple fall premarket; CureVac gains - Investing.com India
CureVac, gold miners, Rocket Lab - TradingView
CureVac Patent Validated in BioNTech Dispute, Infringement Hearing Set for July - Marketscreener.com
PRTG Soars On Mesothelioma Data, NVNO Awaits FDA Decision, CureVac Jumps On Patent News - RTTNews
CureVac’s amended patent upheld by European Patent Office By Investing.com - Investing.com South Africa
European Patent Office declares CureVac mRNA patent valid - Marketscreener.com
CureVac up 13% as court upholds validity of patent in BioNTech spat - Seeking Alpha
CureVac’s amended patent upheld by European Patent Office - Investing.com
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Yahoo Finance
CureVac N.V. (CVAC) Gets Positive Validity Decision In Suit Vs BioNTech (BNTX)Bloomberg - StreetInsider
EQS-News: CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Sharewise
Amundi Sells 54,048 Shares of CureVac (NASDAQ:CVAC) - Defense World
CureVac Stock: Recovery Continues Despite Weekly Fluctuations - Sharewise
CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31% - Yahoo Finance UK
CureVac's CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet - ACCESS Newswire
CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board - ACCESS Newswire
CureVac: The mid-term effect of pipeline pruning -February 21, 2025 at 08:16 am EST - Marketscreener.com
Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now? - Insider Monkey
12 Best Get Rich Fast Stocks To Buy Now - Insider Monkey
A History of Outperforming Analyst Forecasts and Beating the Odds: CureVac N.V (CVAC) - SETE News
CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators - ACCESS Newswire
mRNA Pioneer CureVac Clinches Elite Innovation Status with 1,000-Patent Arsenal - StockTitan
CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year in vaccine race - MSN
CureVac Appoints Klaus Edvardsen as Chief Development Officer - ACCESS Newswire
JMP Securities Reiterates “Market Outperform” Rating for CureVac (NASDAQ:CVAC) - Defense World
CureVac (NASDAQ:CVAC) Shares Gap UpWhat's Next? - MarketBeat
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch (CORRECTED) - Benzinga
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch - Benzinga
CureVac (NASDAQ:CVAC) Trading Down 5.8%Time to Sell? - MarketBeat
Individual investors among CureVac N.V.'s (NASDAQ:CVAC) largest stockholders and were hit after last week's 6.1% price drop - Simply Wall St
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia - MSN
CureVac NV (FRA:5CV) Altman Z-Score : 3.43 (As of Feb. 01, 2025) - GuruFocus.com
CureVac NV (FRA:5CV) Momentum Rank : 7 (As of Feb. 01, 2025) - GuruFocus.com
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - ACCESS Newswire
CureVac (NASDAQ:CVAC) Shares Sold by Ballentine Partners LLC - Defense World
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update - ACCESS Newswire
Brokers Offer Predictions for CureVac FY2025 Earnings - Defense World
CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update - ACCESS Newswire
22,946 Shares in CureVac (NASDAQ:CVAC) Bought by Barclays PLC - Defense World
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 - ACCESS Newswire
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer - ACCESS Newswire
FY2025 EPS Estimates for CureVac Raised by Leerink Partnrs - MarketBeat
Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth - Yahoo Finance
CureVac (NASDAQ:CVAC) Stock Price Down 3.7%What's Next? - MarketBeat
CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update - ACCESS Newswire
CureVac (NASDAQ:CVAC) Shares Up 4.7%Should You Buy? - MarketBeat
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster TestingCureVac (NASDAQ:CVAC) - Benzinga
Jane Street Group LLC Has $235,000 Stock Position in CureVac (NASDAQ:CVAC) - Defense World
Geode Capital Management LLC Lowers Position in CureVac (NASDAQ:CVAC) - Defense World
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):